<DOC>
	<DOCNO>NCT00005168</DOCNO>
	<brief_summary>To determine role apolipoprotein B apolipoprotein A1 etiology coronary artery disease .</brief_summary>
	<brief_title>Hyperapo B Coronary Heart Disease</brief_title>
	<detailed_description>BACKGROUND : Hyperapo B phenotype define elevated plasma level major apoprotein B low density lipoproteins presence normal plasma level low density lipoprotein cholesterol . It demonstrate hyperapo B strongly associate coronary artery disease . In 1984 study begin , independence association risk factor coronary artery disease cigarette smoking , hypertension , low plasma level high density lipoproteins know . The study improve knowledge pathophysiology coronary artery disease genetic biochemical defect hyperapo B hypoalphalipoproteinemia . DESIGN NARRATIVE : Interviews conduct clinical data collect index case spouse , well first degree relative . Risk factor data include blood pressure , blood lipid level , obesity , cigarette smoking , fast blood sugar diabetes , hormone use menopause woman , physical activity , personality score , family history . Clinical data include indication coronary arteriography , history use lipid-lowering agent insulin , presence corneal arcus , xanthomata , xanthelasma , electrocardiogram . To determine apolipoprotein B gene apolipoprotein A1-C3-A4 gene cluster independent predictor premature coronary disease , relation DNA polymeric site within two gene coronary disease investigate use clone DNA fragment molecular probe . To determine apolipoprotein B apolipoprotein A level aggregate family determine hyperapo B hypoalphalipoproteinemia segregate Mendelian trait , genetic analysis conduct 200 index case 900 first degree relative . Studies also conduct linkage hyperapo B haplotype apolipoprotein B gene , hyperapo B Ag polymorphism , hyperalphalipoproteinemia haplotype apolipoprotein A1-C3-A4 gene cluster . The study completion date list record obtain `` End Date '' enter Protocol Registration Results System ( PRS ) record .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<criteria>No eligibility criterion</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>May 2000</verification_date>
</DOC>